Search Results - "CAMP, R. L"

Refine Results
  1. 1

    c-Met is a prognostic marker and potential therapeutic target in clear cell renal cell carcinoma by Gibney, G.T., Aziz, S.A., Camp, R.L., Conrad, P., Schwartz, B.E., Chen, C.R., Kelly, W.K., Kluger, H.M.

    Published in Annals of oncology (01-02-2013)
    “…Activation of the c-Met pathway occurs in a range of malignancies, including papillary renal cell carcinoma (RCC). Its activity in clear cell RCC is less…”
    Get full text
    Journal Article
  2. 2

    HSP90 as a marker of progression in melanoma by McCarthy, M.M., Pick, E., Kluger, Y., Gould-Rothberg, B., Lazova, R., Camp, R.L., Rimm, D.L., Kluger, H.M.

    Published in Annals of oncology (01-03-2008)
    “…HSP90 chaperones molecules critical for cell survival and malignant progression, including mutated B-raf. HSP90-targeting agents are in clinical trials. No…”
    Get full text
    Journal Article
  3. 3

    Growth factor receptor-bound protein-7 (Grb7) as a prognostic marker and therapeutic target in breast cancer by Nadler, Y., González, A.M., Camp, R.L., Rimm, D.L., Kluger, H.M., Kluger, Y.

    Published in Annals of oncology (01-03-2010)
    “…Growth factor receptor-bound protein-7 (Grb7) is an adapter-type signaling protein recruited to various tyrosine kinases, including HER2/neu. Grb7-specific…”
    Get full text
    Journal Article
  4. 4

    Validation of Tissue Microarray Technology in Breast Carcinoma by CAMP, Robert L, CHARETTE, Lori A, RIMM, David L

    Published in Laboratory investigation (01-12-2000)
    “…The recent development of tissue microarray technology has potentiated large-scale retrospective cohort studies using archival formalin-fixed,…”
    Get full text
    Journal Article
  5. 5

    CTGF, intestinal stellate cells and carcinoid fibrogenesis by Kidd, M, Modlin, I M, Shapiro, M D, Camp, R L, Mane, S M, Usinger, W, Murren, J R

    Published in World journal of gastroenterology : WJG (21-10-2007)
    “…To investigate the role of small intestinal carcinoid tumor-derived fibrotic mediators, TGFbeta1 and CTGF, in the mediation of fibrosis via activation of an…”
    Get full text
    Journal Article
  6. 6

    Analysis of p53 protein expression levels on ovarian cancer tissue microarray using automated quantitative analysis elucidates prognostic patient subsets by Psyrri, A, Kountourakis, P, Yu, Z, Papadimitriou, C, Markakis, S, Camp, RL, Economopoulos, T, Dimopoulos, MA

    Published in Annals of oncology (01-04-2007)
    “…Background: p53 protein is regarded as a valuable prognostic marker in cancer with a potential use as a molecular target. Here, we sought to determine the…”
    Get full text
    Journal Article
  7. 7

    Microvessel area using automated image analysis is reproducible and is associated with prognosis in breast cancer by Sullivan, C.A.W., MS, Ghosh, S., PhD, Ocal, I.T., MD, Camp, R.L., MD, PhD, Rimm, David L., MD, PhD, Chung, G.G., MD

    Published in Human pathology (01-02-2009)
    “…Summary Microvessel density may be one measure of tumor associated angiogenesis but is methodologically difficult to standardize and reproduce. We used our…”
    Get full text
    Journal Article
  8. 8

    Met expression is associated with poor outcome in patients with axillary lymph node negative breast carcinoma by Camp, Robert L., Rimm, Eric B., Rimm, David L.

    Published in Cancer (01-12-1999)
    “…BACKGROUND Activation of Met, the receptor for scatter factor/hepatocyte growth factor, is associated with mitogenesis, motogenesis, and decreased cell…”
    Get full text
    Journal Article Conference Proceeding
  9. 9

    β-Catenin Functions Mainly as an Adhesion Molecule in Patients with Squamous Cell Cancer of the Head and Neck by ZIWEI YU, WEINBERGER, Paul M, PROVOST, Elayne, HAFFTY, Bruce G, SASAKI, Clarence, JOE, J, CAMP, R. L, RIMM, D. L, PSYRRI, Amanda

    Published in Clinical cancer research (01-04-2005)
    “…Background: β-catenin, depending on subcellular localization, plays a dual role in carcinogenesis: as a signaling factor (in the nucleus) and as an adhesion…”
    Get full text
    Journal Article
  10. 10

    Tissue microarray: a new technology for amplification of tissue resources by Rimm, D L, Camp, R L, Charette, L A, Costa, J, Olsen, D A, Reiss, M

    Published in The cancer journal (Sudbury, Mass.) (01-01-2001)
    “…Tissue microarrays are a method of harvesting small disks of tissue from a range of standard histologic sections and placing them in an array on a recipient…”
    Get more information
    Journal Article
  11. 11

    Automated quantitative analysis of DCC tumor suppressor protein in ovarian cancer tissue microarray shows association with β-catenin levels and outcome in patients with epithelial ovarian cancer by Bamias, A, Yu, Z, Weinberger, PM, Markakis, S, Kowalski, D, Camp, RL, Rimm, DL, Dimopoulos, MA, Psyrri, A

    Published in Annals of oncology (01-12-2006)
    “…Background: The deleted in colorectal cancer (DCC) protein, the product of DCC tumor suppressor gene, is frequently altered in cancer. Preclinical data…”
    Get full text
    Journal Article
  12. 12

    Reduced contact sensitivity reactions in mice treated with monoclonal antibodies to leukocyte function-associated molecule-1 and intercellular adhesion molecule-1 by Scheynius, A, Camp, RL, Pure, E

    Published in The Journal of immunology (1950) (15-01-1993)
    “…We have investigated the effect of the administration of mAb against leukocyte function-associated molecule-1 (CD11a/CD18) and intercellular adhesion…”
    Get full text
    Journal Article
  13. 13

    CD44 is necessary for optimal contact allergic responses but is not required for normal leukocyte extravasation by CAMP, R. L, SCHEYNIUS, A, JOHANSSON, C, PURE, E

    Published in The Journal of experimental medicine (01-08-1993)
    “…The in vivo administration of certain monoclonal antibodies (mAbs) against the adhesion receptor, CD44, into normal mice induces both a modulation of CD44 from…”
    Get full text
    Journal Article
  14. 14

    A high number of tumor free axillary lymph nodes from patients with lymph node negative breast carcinoma is associated with poor outcome by Camp, Robert L., Rimm, Eric B., Rimm, David L.

    Published in Cancer (01-01-2000)
    “…BACKGROUND Lymph node metastasis is the oldest and most reliable prognostic indicator in breast carcinoma. In the absence of tumor metastasis, draining lymph…”
    Get full text
    Journal Article
  15. 15

    Automated subcellular localization and quantification of protein expression in tissue microarrays by Rimm, David L, Camp, Robert L, Chung, Gina G

    Published in Nature medicine (01-11-2002)
    “…The recent development of tissue microarrays-composed of hundreds of tissue sections from different tumors arrayed on a single glass slide-facilitates rapid…”
    Get full text
    Journal Article
  16. 16

    Aneurysmal Bone Cyst of the Spine With Familial Incidence by DiCaprio, Matthew R, Murphy, Michael J, Camp, Robert L

    Published in Spine (Philadelphia, PA. 1976) (15-06-2000)
    “…STUDY DESIGN.A report of two cases of aneurysmal bone cysts of the spine occurring in a father and daughter. OBJECTIVE.To present an unusual finding of…”
    Get full text
    Journal Article Conference Proceeding
  17. 17

    Role of CCN2/CTGF in the proliferation of Mastomys enterochromaffin-like cells and gastric carcinoid development by Kidd, M, Modlin, I M, Eick, G N, Camp, R L, Mane, S M

    “…Mastomys enterochromaffin-like (ECL) cell proliferation is initially gastrin driven, but once neoplasia develops, cells become gastrin autonomous. We…”
    Get more information
    Journal Article
  18. 18

    Variations in the Cytoskeletal Interaction and Posttranslational Modification of the CD44 Homing Receptor in Macrophages by Camp, Robert L., Kraus, Thomas A., Puré, Ellen

    Published in The Journal of cell biology (01-12-1991)
    “…Murine CD44 is a cell surface glycoprotein that is thought to play a role in leukocyte migration. We studied the structure and expression of CD44 on two…”
    Get full text
    Journal Article
  19. 19
  20. 20